Immune System Diseases and Rheumatology
At Vesalion s.r.o., clinical research in immune system diseases focuses mainly on rheumatoid arthritis and psoriatic arthritis. These studies are designed to test new treatment options, compare how well therapies work, and better understand long-term safety and symptom control in people living with inflammatory joint disease.
- Active psoriatic arthritis and psoriatic arthritis (PsA)
- Rheumatoid arthritis and ACPA-positive rheumatoid arthritis
- Evaluation of new therapies and treatment effectiveness
Research at this site also looks at improving outcomes for patients who have not responded well to earlier treatments, with a strong emphasis on reducing inflammation and supporting better daily function.
Musculoskeletal Diseases
Another major area of work at the site is musculoskeletal disease, especially knee osteoarthritis. The trials aim to assess whether investigational treatments can improve pain, physical function, and overall quality of life for people affected by joint degeneration.
- Knee osteoarthritis
- Relief of pain and improvement of movement
- Testing treatment effectiveness in a common joint condition
These studies reflect a broader effort to find better ways to manage chronic joint symptoms and support everyday mobility.
Skin and Connective Tissue Diseases
Clinical trials in skin and connective tissue diseases at Vesalion s.r.o. include research in moderate to severe plaque psoriasis. The main purpose is to evaluate new therapies that may offer better control of skin symptoms, while also tracking safety and durability of response over time.
- Moderate to severe plaque psoriasis
- Assessment of new treatment options for chronic skin inflammation
- Long-term safety and sustained benefit
This area of research is important for patients whose skin disease remains difficult to manage and who may need more effective long-term care options.





